Showing results (11-20 of 370) with videos related to
Sort By:
Pageof 37
The American Journal of Psychiatry|July 5, 2005
Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trialMark Zimmerman, Iwona Chelminski, Michael A PosternakThe Journal of Nervous and Mental Disease|February 11, 2004
Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples includedMark Zimmerman, Iwona Chelminski, Michael A PosternakThe Journal of Clinical Psychiatry|March 9, 2004
Defining remission on the Montgomery-Asberg depression rating scaleMark Zimmerman, Michael A Posternak, Iwona ChelminskiJournal of Clinical Psychopharmacology|November 28, 2002
Symptom severity and exclusion from antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona ChelminskiJournal of Psychiatric Research|October 2, 2004
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depressionMark Zimmerman, Michael A Posternak, Iwona ChelminskiInternational Clinical Psychopharmacology|June 18, 2004
Implications of using different cut-offs on symptom severity scales to define remission from depressionMark Zimmerman, Michael A Posternak, Iwona ChelminskiComprehensive Psychiatry|February 13, 2007
Heterogeneity among depressed outpatients considered to be in remissionMark Zimmerman, Michael A Posternak, Iwona ChelminskiThe Journal of Nervous and Mental Disease|February 25, 2005
Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?Mark Zimmerman, Michael A Posternak, Iwona ChelminskiThe American Journal of Psychiatry|October 7, 2004
Using a self-report depression scale to identify remission in depressed outpatientsMark Zimmerman, Michael A Posternak, Iwona ChelminskiThe American Journal of Psychiatry|March 1, 2002
Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?Mark Zimmerman, Jill I Mattia, Michael A PosternakPageof 37